INTRODUCTION
Crohn's disease (CD) and ulcerative colitis (UC), the two major types of inflammatory bowel diseases (IBDs), are characterized by continuous or discontinuous mucosal inflammation with inflammatory cell infiltrate, epithelial cell destruction, connective tissue defects, and ulceration of the mucosa. 1, 2 IBD is caused by genetic predisposition, environmental factors, dysregulated immunity, and enteric microbiota, and a combination of these factors results in intestinal injury caused by dysregulated cytokines, nitric oxide, eicosanoids, and proteolytic enzymes.
Matrix metalloproteinases (MMPs) are known to be involved in many physiologic and pathologic processes and they are also upregulated in the context of IBD pathology. [3] [4] [5] [6] [7] [8] [9] [10] The inhibition of MMP activity improves experimental colitis. 11, 12 Unlike most MMPs, MMP-19 is expressed in several healthy tissues, 13, 14 suggesting a role in tissue homeostasis. Epithelial cells of the intestine, 15, 16 peripheral blood mononuclear cells 17 macrophages, 18 and keratinocytes 19 are major producers of this proteinase. MMP-19 processes IGFBP 3 (ref. 19 ) and various ECM components including laminin 5g2 chain, nidogen-1, tenascin C, and aggrecan. [20] [21] [22] [23] Studies using Mmp-19-deficient mice revealed its role in the maturation of thymocytes, 24 accumulation of tenascin-C in bronchial walls in asthma model, 25 beneficial effect in liver 26 and lung 27 fibrosis, and suppression of tumor angiogenesis and invasion. 28, 29 In this report, we demonstrate that MMP-19 is critically involved in increased susceptibility and exacerbation of colitis, maintaining the epithelial barrier function and regulation of the innate immune response, especially the influx of neutrophils.
Neutrophil recruitment is initially delayed; however, À / À mice subsequently develop persistent inflammation. The dysregulated immune response in À / À mice was rescued by bone marrow transplantation from WT mice. Moreover, we found that MMP-19 directly generates a soluble chemokine domain of CX3CL1 and that À / À mice show diminished processing of CX3CL1. Altogether, MMP-19 mediates beneficial effects in intestinal inflammation and is an important factor in healing and homeostasis of the mucosa.
RESULTS

Mmp-19 deficiency results in increased susceptibility to induced colitis
The expression of MMP-19 significantly increases during the development of colitis (Supplementary Figure 1A online ). The experimental model of acute colitis was induced by drinking 2% DSS (Dextran sulphate sodium) for 6 days. While treatment resulted in significant weight loss in both genotypes, Mmp-19
mice experienced a greater relative weight loss (25 vs . 12%, observed in WT; Figure 1a ). This profound difference was associated with a higher disease activity index (DAI) compared to WT mice (4.0 and 2.2 respectively, Figure 1b ), decreased survival (85%) compared to WT mice (100%, Supplementary Figure 1B) , and significant reduction in colon length ( Figure 1c) .
To assess the course of progression of DSS-induced colitis in vivo, signs of inflammation were followed by whole body imaging. Myeloperoxidase (MPO) is an enzyme secreted by neutrophils at the site of inflammation and is widely used as a marker of colitis. To monitor MPO-dependent oxidative stress, luminol-mediated signal was recorded and abdominal areas positive for luminescence were quantified (Figure 1d ; for enlarged images see Supplementary Figure 1C ). While WT animals showed the peak in inflamed area at days 5 and 6, in À / À mice luminescent signals clearly peaked at day 6, indicating a delayed influx of MPO-positive neutrophils.
Histological injury scores were quantified from Hematoxylin staining of 'Swiss rolls' of the entire colon ( Figure 1e ). All DSStreated mice exhibited clear signs of colon inflammation and damage. Extensive lesions in À / À animals were in striking contrast to fewer lesions in WT mice. Scoring for inflamed lesions, ulceration, and crypt damage in the distal colon revealed more severe injury in Mmp-19 (Figure 1f) . By day 8, over 80% of the colon of Mmp-19 À / À mice displayed significantly more lesions when compared to all other groups (Figure 1f) . Nearly 90% of the inflamed mucosa displayed ulceration in Mmp-19 À / À tissues and, unlike WT animals, the ulcerations affected the entire area of the colonic mucosa (data not shown). Quantification of tissue edema, crypt damage, and ulceration depth (Supplementary Figure 2A) further confirmed exacerbation of colitis in À / À mice.
Delayed neutrophil recruitment and augmented cytokine expression in Mmp-19 À / À mice Given our findings in DSS-treated Mmp-19 À / À mice (Figure 1) , we next quantified neutrophils in histological sections ( Figure 2a) . Their amount in the inflamed colon tissue of WT mice peaked at day 2 of treatment at approximately 90% of the total cell count. This was followed by a gradual decrease during the course of the disease, reaching 20% at day 8. Conversely, À / À mice exhibited a slow gradual increase in neutrophil numbers that remained elevated compared to WT values at day 8 ( Figure 2a ; blue (WT) and red (KO) lines). The histological evaluation was supported by a significant increase in myeloperoxidase activity (MPO) at day 8 ( Figure 2b ) correlating with augmented activities of MMP-2 and -9, two major proteinases produced by neutrophils (Figure 2c) . À / À mice showed a 5-fold increase of active MMP-9 and a 4-fold increase of active MMP-2 ( Figure 2c) .
Next we examined whether Mmp-19 deficiency had an impact on inflammatory cells in the peripheral blood and spleen and on inflammatory modulators. DSS-treatment resulted in a 2-fold increase in CD45 þ /CD11b þ /Ly6G/C þ granulocytes in the blood of À / À mice and no differences in the spleen (Figure 2d ). To analyze whether development of acute colitis was accompanied by systemic inflammation, cytokine and chemokine levels in the supernatants of colon explant cultures (CEC) and in plasma of DSS-treated mice were determined. Overall, pro-inflammatory Th1 cytokines like TNF-a and IL-6 were significantly increased in À / À mice compared to WT mice (Supplementary Figure 3A,B) . Other pro-inflammatory factors such as MCP-1, KC, and G-CSF were also significantly augmented in the À / À CEC cultures (Supplementary Figure 3A) , and G-CSF and KC were increased in the plasma of Mmp-19 À / À mice (Supplementary Figure 3B) . Finally, anti-inflammatory Th2 cytokines such as IL-4 and IL-10 were also significantly increased in the colon of Mmp-19 À / À mice suggesting an ongoing immune suppression activity (Supplementary Figure 3) . 
Mmp-19 deficiency leads to persistent inflammation
To study recovery from colitis, mice were treated with 2% DSS for 5 days followed by a recovery phase (standard drinking water for 10 days). Maximum body weight loss was observed on day 8. WT mice lost less body weight when compared to the (Supplementary Figure 2C) . Moreover, infiltration of inflammatory cells, edema, and hyperregeneration indicated a well-established injury in À / À mice (Supplementary Figure 2C) .
Pro-inflammatory cytokine levels were substantially elevated in À / À mice during the recovery phase, pointing to a more systemic immune response. In particular, IL-6 plasma concentrations were 10-fold higher in À / À mice than in WT mice (Supplementary Figure 5) . MCP-1, G-CSF, and KC were also significantly elevated in the plasma of Mmp-19
mice. Highly increased levels of G-CSF indicate the initiation of a systemic response, potentially stimulating granulocyte production. Altogether, Mmp-19 À / À mice showed evidence of persistent inflammation. À / À CEC supernatants, which was consistent with the increased concentrations of chemoattractants (Supplementary Figure 5 ). Also, monocyte, granulocyte, T and B cell counts were higher in Mmp-19 À / À mice (Supplementary Figure 6) . Increased macrophage migration in response to chemoattractant-rich Mmp-19 À / À CEC supernatants was confirmed in the Transwell-chamber migration assay with the RAW264.7 macrophage cell line and the scratch wound healing assay with primary macrophages (Figure 5d) . À / À mice labeled with calcein AM also exhibited significantly decreased transmigration (Figure 5f ). Altogether, these results suggest that the migration capacity of À / À macrophages is diminished; however, stronger pro-inflammatory response in À / À mice is sufficient to override their compromised migratory potential. 
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MMP-19 cleaves the chemokine domain of CX3CL1
Mmp-19 deficiency had no effect on granulopoiesis and mobilization of neutrophils in response to G-CSF as demonstrated by daily administration of G-CSF (Figure 7a and b) and thus we searched for potential mechanisms of deregulated neutrophil influx. We examined also CX3CL1 (fractalkine), a unique chemokine with adhesive and chemotactic properties that is expressed in epithelia. [30] [31] [32] CX3CL1-CX3CR1 signaling is pivotal for the development of inflammatory conditions in intestinal walls [33] [34] [35] and ablation of the receptor leads to a similar phenotype as observed in Mmp-19 À / À mice. 35 Colon tissue lysates and conditioned media from CECs were analyzed by immunoblotting using antibodies against the N-or C-terminus of CX3CL1. The N-terminal detection revealed a fragment of about 40 kDa in Mmp-19 À / À samples which was virtually absent in WT samples (Figure 7c ; for full unedited gels see Supplementary Figure 7A 
DISCUSSION
In this study, we provide functional evidence that MMP-19 controls the inflammatory processes in the intestine and plays a protective role in colitis development. This phenotype partly resembles that of other MMPs. Mmp-7 À / À mice showed delayed re-epithelialization and influx of neutrophils due to alteration of neutrophil chemokines. 36 MMP-2 also exhibits some protective effect. However, MMP-9 had the opposite effect on the course of colitis, with the extent and severity of intestinal epithelial injury being significantly attenuated in the deficient mice. 37, 38 Mmp-9 À / À mice exposed to DSS or S. typhimurium had dramatically reduced inflammation and mucosal injury and showed protection against acute colitis.
38,39
However, bone marrow transplantation showed that loss of granulocyte-derived MMP-9 exacerbated colitis whereas general loss of MMP-9, including MMP-9 of epithelial origin, exhibited attenuation. 39 MMP-19 appears to affect both the epithelium and the inflammatory response. The colonic epithelial barrier in Mmp-19 À / À mice was extensively compromised during the recovery and chronic phases of colitis. Analysis of proteins involved in constituting tight junctions (TJs), and thus paracellular permeability homeostasis, revealed that the colonic epithelium of Mmp-19 À / À mice expresses significantly less claudin-8. Claudin-8 is expressed prevalently in the colon, 40 and together with claudin-5 is responsible for sealing TJs, thus preventing back leakage in the most distal segments of tubular epithelia. 41 The impact of MMP-19 on barrier function may also be due to processing of its substrates found in the basement membrane such as laminin 5g2 chain, nidogen-1, or tenascin C. [20] [21] [22] To distinguish whether Mmp-19 deficiency primarily impacts the epithelia or immune cells during colitis development, Mmp-19 À / À mice were transplanted with WT bone 
marrow cells. These chimeric Mmp-19
À / À mice developed only weak signs of colitis, resembling the disease progression of WT mice. This rescue effect could be explained by a neutrophil migration rate similar to that of WT mice and/or by significantly decreased plasma cytokine levels compared to the controls.
The dysregulated immune response in Mmp-19
À / À mice and its bias towards inflammation is obvious during all phases of DSSinduced colitis. However, most striking is the slower kinetics of neutrophil influx in the acute phase, in which the number of neutrophils in À / À mice increased very slowly. As neutrophils do not express MMP-19, the defect in transmigration into the inflamed tissue was probably a consequence of a lack of expression of an appropriate chemoattractant in the epithelial cells or, mechanically, their removal due to excessive damage. Thus, MMP-19 seems to function as a mediator for neutrophil migration to wounded mucosa.
Besides neutrophils, MMP-19 exhibits a direct impact on migration of macrophages. Using the Transwell-chamber and air-pouch migration assays, we observed a lower migratory capacity of the Mmp-19 À / À macrophages. This finding is in line with our previous data showing association of MMP-19 with the cell-surface of myeloid cells. 18 The observed impaired primary immune reaction might originate from the inability of inflammatory cells to migrate towards the site of injury, either due to the unavailability of attracting mediators, or dysfunction of their signaling pathways. Several MMPs have been identified to be involved in such a control of inflammatory cells. MMP-8 was shown to cleave the N-terminus of both CXCL8/IL-8 and LIX to enhance chemotactic potency and Mmp-8 À / À mice showed impaired recruitment of polymorphonuclear leukocytes in an LPS-induced inflammation model. 42 Other studies have demonstrated roles for MMP-2 and MMP-9 in mobilization of CCL11/eotaxin, CCL7/MCP-3 and CCL17/ TARC. 43 As MMP-19 associates with the cell surface, we examined if MMP-19 is able to process CX3CL1, which is also expressed in the intestinal mucosa 32, 44 and serves as chemoattractant when the chemokine domain is shed by ADAMs. 45, 46 Although most studies showed that CX3CL1 exhibits its main chemoattractive activity towards monocytes, natural killer cells, and T cells, 30, 31 expression of its receptor CX3CR1 was also reported on neutrophils. 47 Brand et al. 33 reported not only the surface expression of CX3CR1 on neutrophils but also that CX3CL1 promotes accumulation of neutrophils in intestinal epithelia. The attraction of neutrophils might not only be a direct effect of CX3CL1 alone but it could further lead to upregulation of IL-8/ KC in intestinal epithelia; IL-8/KC are potent chemoattractants for neutrophils. We show for the first time that MMP-19 cleaves CX3CL1, and that CX3CL1 is not effectively released from colon explants of Mmp-19 À / À mice. In comparison to ADAM17 that cleaves the CX3CL1 stalk proximal to the cell surface, MMP-19 cleaves off only the chemokine domain. The diminished MMP-19-dependent release of CX3CL1 could be partly responsible for dysregulated recruitment of neutrophils and other inflammatory cells. Reduced CX3CL1-mediated signaling might also lead to an impaired capacity of epithelia to recover as CX3CR1 in intestinal epithelial cells promotes cell proliferation. 33 Interestingly, the altered CX3CL1-CX3CR1 axis appeared to be pivotal for mucosal immunity at the background of chronic colitis 48 and CX3CR1 À / À mice exhibit Numbers of neutrophils were determined using flow cytometry in exudates obtained 6, and 24 h after injection. n ¼ 3; *Po0.05, **Po0.01.
impaired intestinal barrier and thinner mucus. 49 Some aspects of our concept of the physiological role of MMP-19-dependent CX3CL1 cleavage remain speculative and need further investigation.
In conclusion, our data provide evidence that MMP-19 has a protective role in colitis by maintaining the colon epithelial barrier and controlling the recruitment of inflammatory cells. Moreover, we provided evidence that MMP-19 sheds the chemokine domain of CX3CL1 revealing thus another important activation component during intestinal inflammation and complexity of MMP19 role in colitis.
METHODS Experimental animals. Mmp-19
À / À mice were described previously. 24 Venus mice were generated using transposon mediated mutagenesis by using Sleeping Beauty transposons (SB100) containing Venus under the CAGGS promoter (gift from L. Mates, MDC Berlin, Germany). The majority of tissues and cell types in Venus mice expressed GFP; the animals were otherwise phenotypically indistinguishable from WT mice. Genotyping is described in Supplementary Material.
DSS-induced colitis model and disease activity scoring. Only males were used for all experiments as a significant gender bias in susceptibility to DSS-induced colitis was reported. 36 Acute colitis was induced by administration of 2% dextran sulphate sodium (DSS; TdB Consultancy) in the drinking water for 6 days, after which mice received 2 days resting period before they were killed. Mice drinking normal water were used as control. Body weight, disease activity index (DAI: calculated using the loss of body weight, intensity of bleeding (Hemoccult Fecal Occult Blood Test, Beckman Coulter) and stool consistency. The recovery phase of colitis was induced by DSS administration for 5 days followed by a 10 days recovery period. In the model of chronic colitis, the latter procedure was repeated twice. DAI scoring is described in Supplementary Material.
Murine colon organ culture. Whole colons were excised and flushed with PBS containing penicillin and streptomycin (PAA). Biopsies from the distal colon (3 Â 8 mm) were excised and the colon explant culture (CEC) set up for 24 h. Culture supernatants were assessed for cytokines/chemokines by ELISA or Bio-Plex Suspension Array System (Bio-Rad Laboratories).
Bone marrow transplantation. Transplants were performed as previously described. 27 Briefly, four-week-old recipients were irradiated with 7.5 Gy at two doses with 5 h interval. The same day, 1-2 Â 10 6 unsorted BM cells isolated from femur of the donors, were injected via the tail vein. Four weeks after the transplantation, acute colitis was induced as described above.
Gelatin zymography. In brief, gels were incubated for 24 h at 37 1C and stained with 0.5% Coomassie Blue R-250 (Sigma-Aldrich). Regions representing the gelatinase activity of MMP-2 and MMP-9 were quantified using AIDA Image Analyser Software (Raytest).
Myeloperoxidase activity measurement. Myeloperoxidase (MPO) activity was measured in snap-frozen samples from distal colon. Equal aliquots of tissue samples were homogenized in MPO buffer (50 mM potassium phosphate buffer (KPO 4 ), pH 6.0, containing 0.5% hexadecyltrimethylammonium bromide (C 19 H 42 BrN), incubated at 60 1C for 2 h. Diluted, clarified samples were mixed with the O-dianisidine and MPO activity was assayed as described elsewhere.
In vivo permeability assay. To measure intestinal permeability, FITC-dextran 4 (4000 MW; TdB Consultancy) dissolved in PBS was administered by oral gavage (0.6 g/kg body weight) to mice fasted for 4 h prior to the experiment. Blood was obtained by retro-orbital bleeding into heparin coated tubes (Microvette CB 300, Sarstedt).
Expression of MUC2 in colon mucus layer. Distal parts of colon tubes were fixed with methanol based Carnoy's fixative and opened tissues were stained with anti MUC2 antibody followed by Alexa 488 conjugated secondary antibody. Subsequently, specimens were soaked with glycerol and screened with Leica SP5 confocal microscope. Total area, number and average size of MUC2 positive patches were used for statistical comparison.
CX3CL1 processing in vitro. The cleavage of CX3CL1 with human GST-MMP-19 and inactive MMP-19 mutant (MMP-19EA) was assayed as described. 19 In brief, 1 mg of human CX3CL1 (R&D Systems) was incubated with recombinant MMP-19 in TNC buffer (50 mM Tris-HCl, 150 mM NaCl, 5 mM MgCl 2 , 5 mM CaCl 2 , pH 7.4) containing 10 mM ZnCl 2 with 4 mg GST-MMP-19 at 37 1C for 35 h. Dorsal air pouch. Assay was performed as described. 50 At day 6, 1 ml of WT, Mmp-19 À / À CEC supernatant (diluted in PBS) or PBS alone (control) was injected into the pouch. Mice were killed 6, 24 or 48 h after injection and infiltrated white blood cells were analyzed by flow cytometry.
Statistics. All parametric data are presented as mean ± s.d. Statistical analyses were performed with GraphPad Prism (GraphPad Software).
Differences between 2 groups were tested using a two-tailed unpaired Student's t test. Two-tailed one-way ANOVA or Kruskal-Wallis test with Dunn's post-test was used for comparison of multiple groups when appropriate. Significance was determined at the level of Po0.05. *Po0.05, **Po0.01, ***Po0.001; the n value is specified in the figure legends. 
